 |
  UCI
Wins a $5.6 Million Grant to Meld Life and Computer Sciences
The funding will be used to expand the interdisciplinary Biomedical
Informatics Training (BIT) program, an initiative led by IGB Director
and Chancellor’s Professor Pierre Baldi (right) and Professor G. Wesley
Hatfield (left) to train graduate students and postdoctoral fellows in the
UCI Donald Bren School of Information and Computer Sciences (ICS), The
Henry Samueli School of Engineering, and the schools of physical
sciences, biological sciences, and medicine.
 UCLA
Researchers Identify Biological Markers That May Predict Diabetes in
Still Healthy People
Reporting in the Aug. 15 issue of the
journal Archives of Internal Medicine, principal investigator Dr.
Simin Liu (right), professor of epidemiology and medicine with a joint
appointment at the UCLA School of Public Health and the David Geffen
School of Medicine at UCLA, and colleagues have identified three
inflammatory cytokines, or messenger molecules — tumor necrosis
factor-alpha (TNF-α), interleukin-6 (IL-6) and high-sensitivity
C-reactive protein (hs-CRP) — that may be one of the causes of Type
2 diabetes, which afflicts roughly 7 percent of the U.S. population.
 Promising
New Nanomedical Cancer Therapy Also Highlights Tech Transfer, Caltech Inventor
Mark Davis (right) Says
Davis's custom-designed nanoparticles
for fighting cancer are currently being tested on patients at City of
Hope in nearby Duarte, and are now in the planning stages for more
extensive phase II trials. The nanoparticles are built to deliver
chemotherapy drugs to tumors in such a way that the adverse effects of
the drugs on the rest of the body are minimized
|
|
|
|
|
|
See
list of open positions at
http://www.socalbio.org/career_center/jobs.htm
|
|
|
|
 |
|
Join
the Southern California Biomedical
Council and Enjoy the Benefits of our
Group Purchasing Program
The SoCalBio Group
Purchasing Program includes the following
providers:
Program discounts and other benefits are offered
exclusively to SoCalBio device, biotech, and R&D
member companies and service providers in Los
Angeles, Orange, Ventura, Santa Barbara, San
Bernardino and Riverside counties.
See
SoCalBio
membership information and benefits at: http://www.socalbio.org/membership/membership_form.htm
|
|
 |
|
Coming
in 9 days
SoCalBio
52nd Networking Forum
August 30, 2007,
5 - 9 pm
USC
Davidson Conference Center
3415 S Figueroa St, LA, CA 90007
RSVP
Now: https://www.123signup.com/register?id=qrsfy
featuring presentation
& discussion focusing on
Are We
Closer to Developing
a True Cancer Vaccine?
Cancer
vaccines hold great promise for providing cancer therapies
that are non-toxic, less-invasive, and
longer-lasting than current treatments. But delivering on this
promise has posed one of the greatest challenges
facing the life sciences. This challenge has been embraced
by the
biotechnology industry.
As a result,
there are now several cancer
vaccines under development by companies such as Genitope Corp (MyVax), Onyvax (Onyvax-P), Antigenics (Oncophage),
Geron Corp. (GRNVAC1), Favrille Inc (FavId), Dendreon Corp
(Provenge), Cell Genesys (GVAX), Advaxis, Inc (Lovaxin C),
GeneMax Corp (AdhTAP) and Apthera (NeuVax).
Notwithstanding
some high-profile failures in trials, e.g., CancerVax's
melanoma vaccine, the opportunities afforded by this
technology space continue to lure new entrants such as the Los
Angeles-based ImmunoCellular Therapeutics. This company
seeks to develop vaccines against malignancies including
brain tumors. Company founder and chairman Dr. John Yu,
co-director of the Comprehensive Brain Tumor Program at
Cedars-Sinai Medical Center, will provide an
overview of the commercial state of cancer vaccine
development and his company's approach in tackling the
challenges of such vaccine design.
A panel
discussion following Dr. Yu's presentation will address
whether we are closer to developing a cancer vaccine.
Participants include local companies such as Agenesys,
Celprogen and MannKind.
|
The SoCalBio
Networking Forum brings together leaders from all
segments of the life-science industry to share
insights and learn about:
-
Innovation
best practices
-
Device
and biotech business trends
-
Technology
convergence opportunities, and
-
Broad-reaching
public policies shaping the commercialization of
innovations and healthcare service delivery in the
U.S. and abroad.
Click
here for examples of past forums |
Thanks
to Forum Sponsors
Sponsorship and Display
Opportunities Available
Contact SoCalBio at scbc@socalbio.org
|
|
|
SoCalBio/LINC
Fall Golf Classic
Click
for more information
September 24, 2007
Marbella Country Club,
San Juan Capistrano
RSVP
Online Thanks
to SoCalBio/LINC
Golf Tournament Sposnors
Interested
in sponsoring the golf tournament?
Contact Colby
Poppleton at (714) 557-5100 ext 16
or Colby@rodheim-marketing.com
|
 |
|
2nd
SoCalBio Human Resources
Conference & Job Fair
February 29, 2008
Wilshire Grand
Hotel in Downtown Los Angeles
Conference
provides a forum for information sharing among HR
executives in device and biotech companies, HR
professionals, educators, and workforce training
providers to address the growing human capital and
employment needs of the life-science industry in
Southern California
Thanks
to Sponsors
Sponsorship
and Display Opportunities Available
Contact SoCalBio at scbc@socalbio.org
|
|
|
10th
SoCalBio Investor
Conference
Thursday, April 10, 2008
with a
pre-conference CEO/Investor
networking dinner on April 9
This
Conference features business presentations by CEOs of
Southern California device, pharmaceutical and e-health
firms interested in raising capital and/or forging
strategic partnerships. This Conference also offers
forums to engage technologists and investors in a
discourse over new models of commercializing
life-science innovations.
Companies
interested in presentation slots should send executive
summaries to scbc@socalbio.org.
Sponsorship
and Display Opportunities Available
Contact SoCalBio at scbc@socalbio.org
|
|
